Articles

The UK's National Health Service (NHS) is reported to be looking at the use of Avastin in lieu of Lucentis.

Posterior lamellar keratoplasty with DSAEK is a new surgical technique for the treatment of endothelial corneal diseases.

TearScience, has completed a $44.5 million of Series C funding from new investors.

Optos's scanning laser ophthalmoscope devices, the P200, P200C and P200MA have been used in a number of clinical studies, aimed at evaluating the effectiveness of an optomap ultra-widefield retinal scan in detecting potentially harmful lesions in the retina.

Highlighting the many developments from the burgeoning field of oculogenetics, Dr Edwin M. Stone, PhD, focuses on a successful gene therapy experiment, the increasing availability of clinical trials, and new technology that enhances genetic testing.

An approach to pre-treating two corneal conditions that makes for better refractive surgery by Asim Piracha, MD, Louisville, Kentucky, has been published in the Review of Ophthalmology.

The World Congress on Controversies In Ophthalmology (COPHy) will take place in Barcelona, Spain, from 3?6 March 2011, following the first event held in the Czech Republic in March this year.

The new AlphaSphere Orbital Implant ophthalmic device has been awarded the 2010 Alpha Award for Innovation In Engineering & Technology presented by the Engineering Society of Detroit.

Critical Health has announced that Retmarker, its software solution for decision support in the ophthalmology domain, attained the right to hold the CE 0197 branding, that classifies it as a Class IIa Medical Device at a European level.

"Why was Lucentis, at $2000 per dose chosen for the study, rather than Avastin at $50 per dose?? so asked Irv Arons in his blog spot.

As the World Ophthalmology Congress in Berlin approaches look out for OTEurope's special interactive preview issue

Arnall Patz, MD, might not have had instant name recognition among most Americans, but among ophthalmologists, he was a legend.

Recent studies in animal models provide a possible explanation for the reason that ageing predisposes the eye to glaucoma and suggest that dietary manipulation could modify this ageing process.

Although it would appear neuroprotective agents for glaucoma will not be available any time soon, research in Alzheimer?s disease and in animal models of glaucoma is generating findings that suggest several promising approaches.

The safety and efficacy of corneal collagen cross-linking with topical riboflavin and UV-A irradiation for the treatment of keratoconus and ectasia after refractive surgery is being investigated in a US clinical trial. Data from an interim analysis of eyes that have reached the 3-month follow-up visit are encouraging.

The Diabetic Retinopathy Clinical Research Network (DRCR.net) study, published in Ophthalmology online has shown that ranibizumab (Lucentis) injections, in combination with laser treatment has produced better vision results than in patients treated by laser alone for diabetic macular oedema (DME).

Researchers in the Howe Laboratory, Department of Ophthalmology of the Massachusetts Eye and Ear Infirmary and Harvard Medical School, and in the University of Oklahoma Health Sciences Center, have used a novel model to determine what part of the virus is responsible for the inflammation in viral keratoconjunctivitis

Scientific studies show that the inclusion of high levels of omega-3 fatty acids, lutein and zeaxanthin in the diet supports eye health.

LensAR, Inc has issued a patent addressing methods for using laser technology to increase the flexibility of the ocular lens in order to both restore accommodation in presbyopia patients and allow easier removal of hardened lenses in cataract patients.

Addition Technology, Inc., the maker of Intacs corneal implants, AlphaSphere orbital implants and the AlphaCor artificial cornea has received FDA approval for an expanded range of additional sizes of Intacs corneal implants for keratoconus.

The mobile version of Topcon Medical Systems's EyeRoute Image Management Suite is now available as a dedicated iPhone application

Rayner Intraocular Lenses Limited has globally launched its T-flex Aspheric toric IOL.

Carl Zeiss Meditec has announced that ReLEx, the first femtosecond-only method of laser vision correction, is now available for sale outside the United States.1 ReLEx is a new application that allows ophthalmic surgeons to perform a variety of complete laser vision correction procedures using only the VisuMax Femtosecond laser.

Scientists from the Mayo Clinic and Mayo Foundation in the USA have studied 135 patients with intermittent exotropia, where the eye turns outwards while looking at an object, over a 20-year period.

Heidelberg Engineering is introducing SPECTRALIS, then office-based imaging device for tracking and measuring axonal change, at the 2010 meeting of the American Academy of Neurology in Toronto.

A rare opportunity to acquire a 500-page hand-written manuscript of prominent case studies of eye injuries and diseases at Moorfields Hospital is now possible

pSivida Corp. a developer of ophthalmic sustained release drug delivery products, has said that a recently-published peer reviewed scientific paper showed that a sustained release Durasert drug delivery device releasing the steroid fluocinolone acetonide (FA) in the back of the eye preserved retinal function in a retinitis pigmentosa model.

Oraya Therapeutics has been granted the CE mark for its IRay system, which its researchers say can deliver low-energy X-rays to treat wet AMD.

Highlights from an expert roundtable meeting can be found in the April issue of Ophthalmology Times Europe.

The Review of Ophthalmology recently published a survey amongst surgeons which indicates that toric IOLs are becoming more popular for managing astigmastism in cataract patients. The results also demonstrated a move away from bimanual surgery and the mixing of presbyopic IOLs.